These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 15333514)

  • 1. High absorption but very low bioavailability of oral resveratrol in humans.
    Walle T; Hsieh F; DeLegge MH; Oatis JE; Walle UK
    Drug Metab Dispos; 2004 Dec; 32(12):1377-82. PubMed ID: 15333514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and bioavailability of trans-resveratrol.
    Wenzel E; Somoza V
    Mol Nutr Food Res; 2005 May; 49(5):472-81. PubMed ID: 15779070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of trans-resveratrol from red wine in humans.
    Vitaglione P; Sforza S; Galaverna G; Ghidini C; Caporaso N; Vescovi PP; Fogliano V; Marchelli R
    Mol Nutr Food Res; 2005 May; 49(5):495-504. PubMed ID: 15830336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of resveratrol.
    Walle T
    Ann N Y Acad Sci; 2011 Jan; 1215():9-15. PubMed ID: 21261636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absorption, distribution, metabolism and excretion of Riccardin D in rats.
    Ling X; Xing J; Zhang JZ; Chen WF; Zan X; Du FY; Li XX; Yao H; Lou HX
    Drug Res (Stuttg); 2013 Mar; 63(3):159-64. PubMed ID: 23430703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.
    Rotches-Ribalta M; Urpi-Sarda M; Llorach R; Boto-Ordoñez M; Jauregui O; Chiva-Blanch G; Perez-Garcia L; Jaeger W; Guillen M; Corella D; Tinahones FJ; Estruch R; Andres-Lacueva C
    J Chromatogr A; 2012 Nov; 1265():105-13. PubMed ID: 23089514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol transport and metabolism by human intestinal Caco-2 cells.
    Kaldas MI; Walle UK; Walle T
    J Pharm Pharmacol; 2003 Mar; 55(3):307-12. PubMed ID: 12724035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.
    Wenzel E; Soldo T; Erbersdobler H; Somoza V
    Mol Nutr Food Res; 2005 May; 49(5):482-94. PubMed ID: 15779067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
    Kapetanovic IM; Muzzio M; Huang Z; Thompson TN; McCormick DL
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):593-601. PubMed ID: 21116625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of resveratrol bioavailability in the perfused small intestine of the rat.
    Andlauer W; Kolb J; Siebert K; Fürst P
    Drugs Exp Clin Res; 2000; 26(2):47-55. PubMed ID: 10894555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.
    Burkon A; Somoza V
    Mol Nutr Food Res; 2008 May; 52(5):549-57. PubMed ID: 18435437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.
    Shu XH; Li H; Sun Z; Wu ML; Ma JX; Wang JM; Wang Q; Sun Y; Fu YS; Chen XY; Kong QY; Liu J
    Biochem Pharmacol; 2010 May; 79(10):1516-25. PubMed ID: 20105429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
    Lançon A; Hanet N; Jannin B; Delmas D; Heydel JM; Lizard G; Chagnon MC; Artur Y; Latruffe N
    Drug Metab Dispos; 2007 May; 35(5):699-703. PubMed ID: 17287390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.
    Marier JF; Vachon P; Gritsas A; Zhang J; Moreau JP; Ducharme MP
    J Pharmacol Exp Ther; 2002 Jul; 302(1):369-73. PubMed ID: 12065739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers.
    Almeida L; Vaz-da-Silva M; Falcão A; Soares E; Costa R; Loureiro AI; Fernandes-Lopes C; Rocha JF; Nunes T; Wright L; Soares-da-Silva P
    Mol Nutr Food Res; 2009 May; 53 Suppl 1():S7-15. PubMed ID: 19194969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
    Kanai M; Imaizumi A; Otsuka Y; Sasaki H; Hashiguchi M; Tsujiko K; Matsumoto S; Ishiguro H; Chiba T
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):65-70. PubMed ID: 21603867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
    Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
    Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.